Erratum: Biosynthesis of the immunosuppressants FK506, FK520, and rapamycin involves a previously undescribed family of enzymes acting on chorismate (Proceedings of the National Academy of Sciences of the United States of America (2011) 108 (4776-4781) DOI: 10.1073/pnas.1015773108);Biosynthesis of the immunosuppressants FK506, FK520, and rapamycin involves a previously undescribed family of enzymes acting on chorismate

Proceedings of the National Academy of Sciences of the United States of America

Volumn 108, Issue 12, 2011, Pages 4776-4781

  Andexer, Jennifer N ^a,d   Kendrew, Steven G ^b   Nur e Alam, Mohammad ^b   Lazos, Orestis ^a   Foster, Teresa A ^b   Zimmermann, Anna Sophie ^a   Warneck, Tony D ^b   Suthar, Dipen ^b   Coates, Nigel J ^b   Koehn, Frank E ^c   Skotnicki, Jerauld S ^c   Carter, Guy T ^c   Gregory, Matthew A ^b   Martin, Christine J ^b   Moss, Steven J ^b   Leadlay, Peter F ^a   Wilkinson, Barrie ^b  

^a BIOTICA TECHNOLOGY LTD   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c PFIZER INC   (United States)

^d UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Calcineurin; mTOR

Indexed keywords

3 HYDROXYBENZOIC ACID; 4,5 DIHYDROXYCYCLOHEXA 1,5 DIENECARBOXYLIC ACID; ASCOMYCIN; CHORISMIC ACID; IMMUNOPHILIN; RAPAMYCIN; TACROLIMUS; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL STRAIN; BIOSYNTHESIS; CELL PROLIFERATION; DRUG BINDING; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME ACTIVITY; GENE CLUSTER; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROLYSIS; IN VITRO STUDY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PHYLOGENY; PRIORITY JOURNAL; PROTEIN EXPRESSION; STREPTOMYCES HYGROSCOPICUS;

STREPTOMYCES HYGROSCOPICUS;

EID: 79953173626     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1904551116     Document Type: Erratum

References (53)

1. Salituro GM, et al. (1995) Meridamycin: A novel nonimmunosuppresive FKBP12 ligand from Streptomyces hygroscopicus. Tetrahedron Lett 36:997-1000.
2. Fehr T, et al. (1996) Antascomicins A, B, C, D and E. Novel FKBP12 binding compounds from a Micromonospora strain. J Antibiot 49:230-233.
3. Van Duyne GD, Standaert RF, Karplus PA, Schreiber SL, Clardy J (1993) Atomic structures of the human immunophilin FKBP-12 complexes with FK506 and rapamycin. J Mol Biol 229:105-124. (Pubitemid 23037917)
4. Paiva NL, Roberts MF, Demain AL (1993) The cyclohexane moiety of rapamycin is derived from shikimic acid in Streptomyces hygroscopicus. J Ind Microbiol 12:423-428. (Pubitemid 24071713)
5. Zoncu R, Efeyan A, Sabatini DM (2011) mTOR: From growth signal integration to cancer, diabetes and ageing. Nat Rev Mol Cell Biol 12:21-35.
6. Slavin L, Chhabra A, Tobis JM(2007) Drug-eluting stents: Preventing restenosis. Cardiol Rev 15:1-12. (Pubitemid 46005943)
7. Vignot S, Faivre S, Aguire D, Raymond E (2005) mTOR-targeted therapy of cancer with rapamycin derivatives. Ann Oncol 16:525-537. (Pubitemid 40613318)
8. Ruan B, et al. (2008) Binding of rapamycin analogs to calcium channels and FKBP52 contributes to their neuroprotective activities. Proc Natl Acad Sci USA 105:33-38.
9. Klettner A, Herdegen T (2003) FK506 and its analogs-Therapeutic potential for neurological disorders. Curr Drug Targets CNS Neurol Disord 2:153-162.
10. Tain LS, et al. (2009) Rapamycin activation of 4E-BP prevents parkinsonian dopaminergic neuron loss. Nat Neurosci 12:1129-1135.
11. Spilman P, et al. (2010) Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-beta levels in a mouse model of Alzheimer's disease. PLoS One 5(4):e9979.
12. Caccamo A, Majumder S, Richardson A, Strong R, Oddo S (2010) Molecular interplay between mammalian target of rapamycin (mTOR), amyloid-beta, and tau: Effects on cognitive impairments. J Biol Chem 285:13107-13120.
13. Harrison DE, et al. (2009) Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature 460:392-395.
14. Miller RA, et al. (2011) Rapamycin, but not resveratrol or simvastatin, extends life span of genetically heterogeneous mice. J Gerentol A Biol Sci Med Sci 66:191-201.
15. Schwecke T, et al. (1995) The biosynthetic gene cluster for the polyketide immunosuppressant rapamycin. Proc Natl Acad Sci USA 92:7839-7843.
16. Aparicio JF, et al. (1996) Organization of the biosynthetic gene cluster for rapamycin in Streptomyces hygroscopicus: Analysis of the enzymatic domains in the modular polyketide synthase. Gene 169:9-16. (Pubitemid 26076611)
17. Molnár I, et al. (1996) Organisation of the biosynthetic gene cluster for rapamycin in Streptomyces hygroscopicus: Analysis of genes flanking the polyketide synthase. Gene 169:1-7. (Pubitemid 26076610)
18. König A, et al. (1997) The pipecolate-incorporating enzyme for the biosynthesis of the immunosuppressant rapamycin: Nucleotide sequence analysis, disruption and heterologous expression of rapP from Streptomyces hygroscopicus. Eur J Biochem 247:526-534. (Pubitemid 27308631)
19. Lowden PAS, Böhm GA, Staunton J, Leadlay PF (1996) The nature of the starter unit for the rapamycin polyketide synthase. Angew Chem Int Edit 35:2249-2251.
20. Lowden PAS, et al. (2001) Origin and true nature of the starter unit for the rapamycin polyketide synthase. Angew Chem Int Edit 40:777-779. (Pubitemid 32179746)
21. Wallace KK, et al. (1994) Biosynthetic studies of ascomycin (FK520): Formation of the (1R;3R;4R)-3,4-dihydroxycyclohexanecarboxylic acid-derived moiety. J Am Chem Soc 116:11600-11601. (Pubitemid 127657985)
22. Reynolds KA, et al. (1997) Biosynthesis of the shikimate-derived starter unit of the immunosuppressant ascomycin: Stereochemistry of the 1,4-conjugate elimination. J Antibiot 50:701-703. (Pubitemid 27401710)
23. Floss HG (1997) Natural products derived from unusual variants of the shikimate pathway. Nat Prod Rep 14:433-452.
24. Chen S, et al. (1999) Biosynthesis of ansatrienin (mycotrienin) and napthomycin. Identification and analysis of two separate biosynthetic gene clusters in Streptomyces collinus Tü1892. Eur J Biochem 261:98-107. (Pubitemid 29166073)
25. Cropp TA, Wilson DJ, Reynolds KA (2000) Identification of a cyclohexylcarbonyl CoA biosynthetic gene cluster and application in the production of doramectin. Nat Biotechnol 18:980-983. (Pubitemid 32977380)
26. Motamedi H, Cai SJ, Shafiee A, Elliston KO (1997) Structural organization of a multifunctional polyketide synthase involved in the biosynthesis of the macrolide immunosuppressant FK506. Eur J Biochem 244:74-80. (Pubitemid 27079698)
27. Motamedi H, Shafiee A (1998) The biosynthetic gene cluster for the macrolactone ring of the immunosuppressant FK506. Eur J Biochem 256:528-534. (Pubitemid 28440418)
28. Wu K, Chung L, Revill WP, Katz L, Reeves CD (2000) The FK520 gene cluster of Streptomyces hygroscopicus var ascomyceticus (ATCC 4891) contains genes for biosynthesis of unusual polyketide extender units. Gene 251:81-90. (Pubitemid 30339418)
29. Gregory MA, et al. (2004) Isolation and characterization of pre-rapamycin, the first macrocyclic intermediate in the biosynthesis of the immunosuppressant rapamycin by S. hygroscopicus. Angew Chem Int Edit 43:2551-2553. (Pubitemid 39257723)
30. Gregory MA, et al. (2005) Mutasynthesis of rapamycin analogues through the manipulation of a gene governing starter unit biosynthesis. Angew Chem Int Edit 44:4757-4760. (Pubitemid 41059178)
31. Burman JD, Stevenson CE, Sawers RG, Lawson DM (2007) The crystal structure of Escherichia coli TdcF, a member of the highly conserved YjgF/YER057/UK114 family. BMS Struct Biol 7:30.
32. Lowden PAS, Böhn GA, Metcalfe S, Staunton J, Leadlay PF (2004) New rapamycins by precursor-directed biosynthesis. ChemBioChem 5:535-538.
33. Kelley LA, Sternberg MJE (2009) Protein structure prediction on the web: A case study using the Phyre server. Nat Protoc 4:363-371.
34. Walsh CT, Liu J, Rusnak F, Sakaitani M (1990) Molecular studies on enzymes in chorismate metabolism and the enterobactin biosynthetic pathway. Chem Rev 90:1105-1129.
35. Rusnak F, Liu J, Quinn N, Berchtold GA, Walsh CT (1990) Subcloning of the enterobactin biosynthetic gene entB: Expression, purification, characterization, and substrate specificity of isochorismatase. Biochemistry 29:1425-1435.
36. Silakowski B, et al. (2000) The myxochelin iron transport regulon of the myxobacterium Stigmatella aurantiaca Sg a15. Eur J Biochem 267:6476-6485.
37. Gaitatzis N, Kunze B, Müller R (2001) In vitro reconstitution of the myxochelin biosynthetic machinery of Stigmatella aurantiaca Sg a15: Biochemical characterization of a reductive release mechanism from nonribosomal peptide synthetases. Proc Natl Acad Sci USA 98:11136-11141.
38. Müller R, Breuer M, Wagener A, Schmidt K, Leistner E (1996) Bacterial production of trans-dihydroxycyclohexadiene carboxylates by metabolic pathway engineering. Microbiology 142:1005-1012. (Pubitemid 26139375)
39. Franke D, et al. (2003) (S;S)-2,3-Dihydroxy-2,3-dihydrobenzoic acid: Microbial access with engineered cells of Escherichia coli and application as starting material in natural-product synthesis. Chemistry 9:4188-4196.
40. Altschul SF, et al. (1997) Gapped BLAST and PSI-BLAST: A new generation of protein database search programs. Nucleic Acids Res 25:3389-3402. (Pubitemid 27359211)
41. Thompson JD, Higgins W, Gibson TJ (1994) CLUSTAL W: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, positionspecific gap penalties and weight matrix choice. Nucleic Acids Res 22:4673-4680. (Pubitemid 24354800)
42. Ruan X, Stassi D, Lax SA, Katz L (1997) A second type-I PKS gene cluster isolated from Streptomyces hygroscopicus ATCC 29253, a rapamycin-producing strain. Gene 203:1-9. (Pubitemid 27521693)
43. Hayashi Y, et al. (2008) Cloning of the gene cluster responsible for the biosynthesis of brasilicardin A, a unique diterpenoid. J Antibiot 61:164-174.
44. Poplawsky AR, Urban SC, ChunW(2000) Biological role of xanthomonadin pigments in Xanthomonas campestris pv. campestris. Appl Environ Microb 66:5123-5127. (Pubitemid 32217107)
45. Starr MP, Jenkins CL, Bussey LB, Andrewes AG (1977) Chemotaxonomic significance of the xanthomonadins, novel brominated aryl-polyene pigments produced by bacteria of the genus Xanthomonas. Arch Microbiol 113:1-9. (Pubitemid 8097074)
46. Goel AK, Rajagopal L, Sonti RV (2001) Pigment and virulence deficiencies associated with mutations in the aroE gene of Xanthomonas oryzae pv. oryzae. Appl Environ Microbiol 67:245-250. (Pubitemid 32044425)
47. Poplawsky AR, Walters DM, Rouviere PE, ChunW(2005) A gene for a dioxygenase-like protein determines the production of the DF signal in Xanthomonas campestris pv. Campestris. Mol Plant Pathol 6:653-657. (Pubitemid 44944277)
48. He Y-W, Zhang L-H (2008) Quorum sensing and virulence regulation in Xanthomonas campestris. FEMS Microbiol Rev 32:842-857.
49. Dosselaere F, Vanderleyden J (2001) A metabolic node in action: Chorismate-utilizing enzymes in microorganisms. Crit Rev Microbiol 27:75-131. (Pubitemid 32592377)
50. Van Lanen SG, Lin S, Shen B (2008) Biosynthesis of the enediyne antitumor antibiotic C-1027 involves a new branching point in chorismate metabolism. Proc Natl Acad Sci USA 105:494-499. (Pubitemid 351171736)
51. Gregory MA, et al. (2006) Rapamycin biosynthesis: Elucidation of gene product function. Org Biomol Chem 4:3565-3568.
52. Kuščer E, et al. (2007) Roles of rapH and rapG in positive regulation of rapamycin biosynthesis in Streptomyces hygroscopicus. J Bacteriol 189:4756-4763. (Pubitemid 47025587)
53. Drummond AJ, et al. (2010) Geneious v5.1., available at http://www.geneious.com.